What days of the menstrual cycle should I have intercourse while taking letrozole for ovulation induction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Intercourse While Taking Letrozole for Ovulation Induction

Have intercourse every 1-2 days starting on cycle day 8 and continuing through cycle day 19, or use urinary ovulation predictor kits to detect the LH surge and then have intercourse when detected and continue for 2-3 days. 1

Understanding Letrozole's Mechanism and Timing

Letrozole is an aromatase inhibitor that induces ovulation by suppressing estrogen levels, which triggers increased FSH production and follicular development. 2 The medication is typically administered for 5 days early in the menstrual cycle (commonly days 3-7 or days 5-9), with ovulation occurring approximately 5-10 days after the last dose. 2, 3

Two Evidence-Based Intercourse Strategies

Strategy 1: Regular Intercourse During the Fertile Window

  • Begin intercourse every 1-2 days starting soon after menstruation ends (around cycle day 8). 1
  • Continue through cycle day 19 of your menstrual cycle. 1
  • This approach ensures coverage of the fertile window without requiring ovulation prediction, as the timing of ovulation varies considerably even with letrozole-induced cycles. 1

Strategy 2: Ovulation Predictor Kit-Guided Approach

  • Start using urinary ovulation predictor kits several days before expected ovulation. 1
  • When the LH surge is detected (indicating ovulation will occur in 24-36 hours), begin intercourse immediately. 1
  • Continue intercourse for 2-3 consecutive days after detecting the surge. 1

Critical Timing Considerations Specific to Letrozole

The fertile window timing applies to women with regular cycles (26-32 days), which is the typical target population for letrozole ovulation induction. 1 However, letrozole's proximity to conception creates unique considerations:

  • Letrozole is administered early in the cycle specifically to induce follicular development before ovulation. 2, 4
  • The medication must be cleared from your system before conception occurs, which happens naturally given the timing of administration versus ovulation. 4
  • Studies demonstrate that letrozole significantly increases ovulation rates compared to clomiphene citrate (the alternative first-line agent), making precise timing of intercourse even more important. 2, 5

Practical Implementation Algorithm

If you have regular monitoring with ultrasound:

  • Follow your physician's specific instructions based on follicle size and development
  • Typically, intercourse is recommended when the dominant follicle reaches 18-20mm in diameter 3

If you are not having ultrasound monitoring:

  • Use Strategy 1 (intercourse every 1-2 days from cycle day 8-19) if you prefer a simpler approach that doesn't require testing 1
  • Use Strategy 2 (ovulation predictor kits) if you want to minimize the frequency of intercourse while maximizing conception chances 1

Important Caveats

Cycle length matters: These recommendations assume regular cycles of 26-32 days. 1 If your cycles are shorter than 26 days, ovulation occurs earlier and you should begin intercourse around cycle day 6-11. 1 If cycles are longer or irregular, ovulation prediction becomes more critical as the fertile window shifts unpredictably. 1

The 6-day fertile window varies considerably even among women with regular cycles, so the every-1-2-days approach provides better coverage than trying to pinpoint exact ovulation timing. 1

Avoid most commercially available vaginal lubricants, as these may reduce fertility. 1

Related Questions

What are the next steps for a patient with polycystic ovary syndrome (PCOS) on letrozole (aromatase inhibitor) induction who experiences ovulation bleeding on day 12, followed by thick transparent white discharge and increased libido from day 23 onwards?
What is the likely cause of bleeding on days 14 and 15 in a 34-year-old female with a history of letrozole (letrozole is a non-steroidal competitive inhibitor of the aromatase enzyme, generic name) induction, who had a corpus luteum on day 12, and had sexual contact around the time of ovulation?
What is the next step in management for a female patient on letrozole (aromatase inhibitor) induction who ovulated on day 11 of her menstrual cycle and experienced spotting on days 14, 15, and 16?
What are the next steps for a 34-year-old female with infertility undergoing letrozole (aromatase inhibitor) induction, who experienced mild bleeding around day 14 or 15 of her cycle, following detection of a corpus luteum on day 12 ultrasound?
What is the optimal dose and timing of letrozole (aromatase inhibitor) for ovulation induction?
What is the appropriate management of a uvular blister, including airway assessment and indications for supportive care, antiviral, antibiotic, or corticosteroid therapy?
How should I manage oxalate renal stone in a patient with obesity (BMI 38 kg/m²), non‑alcoholic fatty liver disease, hypercholesterolemia who is taking apixaban and candesartan?
Is low‑dose aspirin 100 mg taken once daily recommended for adults with Lynch syndrome?
Is olanzapine 5 mg more likely to cause affective flattening than risperidone 2 mg?
What is the recommended post‑hospital management for a patient treated for acute coronary syndrome?
When should I use non‑contrast computed tomography (NCCT) versus spiral (helical) CT?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.